Suppr超能文献

人参皂苷CK而非Rb1在人类胃癌中通过调节PI3K/AKT/NF-κB信号通路具有潜在的化学预防活性。

Ginsenoside CK, rather than Rb1, possesses potential chemopreventive activities in human gastric cancer regulating PI3K/AKT/NF-κB signal pathway.

作者信息

Wan Yan, Liu Dong, Xia Jia, Xu Jin-Feng, Zhang Li, Yang Yu, Wu Jiao-Jiao, Ao Hui

机构信息

State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Front Pharmacol. 2022 Sep 29;13:977539. doi: 10.3389/fphar.2022.977539. eCollection 2022.

Abstract

Ginsenoside Rb1, a main component of ginseng, is often transformed into ginsenoside CK by intestinal flora to exert various pharmacological activity. However, it remains unclear whether ginsenoside CK is responsible for the anti-gastric cancer effect of ginsenoside Rb1 . In this study, network pharmacology was applied to predict the key signal pathways of ginsenoside Rb1 and ginsenoside CK when treating gastric cancer. The anti-proliferative effects of ginsenoside Rb1 and ginsenoside CK and the underlying mechanism in gastric cancer cells were explored by MTT, Hoechst3328 staining, ELISA, RT-qPCR and Western blotting. The results showed that PI3K-AKT/NF-κB signal pathway was the common important pathway of ginsenoside Rb1 and CK in the treatment of gastric cancer. The results of MTT assay showed that ginsenoside Rb1 could hardly inhibit the proliferation of HGC-27 cells, whereas ginsenoside CK could inhibit the proliferation of HGC-27 cells. Hoechst3328 staining showed that cells in the ginsenoside CK group were densely stained bright blue and nuclear fragmented, indicating that apoptosis occurred. ELISA results showed that ginsenoside CK could effectively downregulate the levels of cyclin CyclinB1 and CyclinD1, but ginsenoside Rb1 had no significant effect. Also, the results of Western blot and RT-qPCR showed that ginsenoside CK inhibited the expressions of anti-apoptosis-related protein Bcl-2 and apoptosis-related pathway PI3K/AKT/NF-κB, and promoted the expression of pro-apoptosis proteins Bax and Caspase 3, whereas ginsenoside Rb1 exerted no effect. In short, ginsenoside Rb1 had no anti-gastric cancer cell activity , but ginsenoside CK could effectively inhibit cell proliferation and induce cell apoptosis in HGC-27 cells. The mechanism might relate to the inhibitory effect of ginsenoside CK on the PI3K/AKT/NF-κB pathway. These results suggest that ginsenoside CK might be the material basis for the anti-gastric cancer activity of ginsenosides.

摘要

人参皂苷Rb1是人参的主要成分之一,常被肠道菌群转化为人参皂苷CK以发挥多种药理活性。然而,人参皂苷CK是否是人参皂苷Rb1抗胃癌作用的原因仍不清楚。在本研究中,应用网络药理学预测人参皂苷Rb1和人参皂苷CK治疗胃癌的关键信号通路。通过MTT法、Hoechst3328染色、ELISA、RT-qPCR和蛋白质免疫印迹法探讨人参皂苷Rb1和人参皂苷CK对胃癌细胞的抗增殖作用及其潜在机制。结果表明,PI3K-AKT/NF-κB信号通路是人参皂苷Rb1和CK治疗胃癌的共同重要通路。MTT法检测结果显示,人参皂苷Rb1几乎不能抑制HGC-27细胞的增殖,而人参皂苷CK能抑制HGC-27细胞的增殖。Hoechst3328染色显示,人参皂苷CK组细胞被染成密集亮蓝色且细胞核碎片化,表明发生了细胞凋亡。ELISA结果显示,人参皂苷CK能有效下调细胞周期蛋白CyclinB1和CyclinD1的水平,但人参皂苷Rb1无显著作用。此外,蛋白质免疫印迹和RT-qPCR结果显示,人参皂苷CK抑制抗凋亡相关蛋白Bcl-2和凋亡相关通路PI3K/AKT/NF-κB的表达,促进促凋亡蛋白Bax和Caspase 3的表达,而人参皂苷Rb1无此作用。总之,人参皂苷Rb1无抗胃癌细胞活性,但人参皂苷CK能有效抑制HGC-27细胞增殖并诱导其凋亡。其机制可能与人参皂苷CK对PI3K/AKT/NF-κB通路的抑制作用有关。这些结果表明,人参皂苷CK可能是人参皂苷抗胃癌活性的物质基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fddc/9556731/e6c7f7ce7341/fphar-13-977539-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验